Undiagnosed hypertrophic obstructive cardiomyopathy during transcatheter aortic valve replacement: A case report

被引:9
|
作者
Olsen K.R. [1 ]
Lagrew J.E. [1 ]
Awoniyi C.A. [1 ,2 ]
Goldstein J.C. [1 ,2 ]
机构
[1] Department of Anesthesiology, University of Florida, College of Medicine, Gainesville, FL
[2] North Florida/South Georgia Veterans Affairs Medical Center, 1601 SW Archer Road, Gainesville, 32608, FL
关键词
Aortic stenosis; Hypertrophic obstructive cardiomyopathy; TAVR; Transcatheter aortic valve replacement;
D O I
10.1186/s13256-018-1904-8
中图分类号
学科分类号
摘要
Background: Transcatheter aortic valve replacement is indicated for severe symptomatic aortic stenosis in patients who have a very high or prohibitive surgical risk as assessed pre-procedurally by the Society of Thoracic Surgery Risk Score, EuroSCORE (II), frailty testing, and other predictors. When combined with another left ventricular outflow tract obstruction, careful consideration must be taken prior to proceeding with transcatheter aortic valve replacement because an additional masked left ventricular outflow tract pathology can lead to challenging hemodynamics in the peri-deployment phase, as reported in this case. Case presentation: A 56-year-old Caucasian man with multiple comorbidities and severe aortic stenosis underwent transcatheter aortic valve replacement under monitored anesthesia care. During the deployment phase, he developed dyspnea that progressed to pulmonary edema requiring emergent conversion to general anesthesia, orotracheal intubation, acute respiratory distress syndrome-type ventilation, and vasopressor medications. Intraoperative transesophageal echocardiography was performed and hypertrophic obstructive cardiomyopathy with systolic anterior motion of the mitral valve was discovered as an underlying pathology, undetected on preoperative imaging. After treatment with beta blockers, fluid resuscitation, and alpha-1 agonists, he stabilized and was eventually discharged from our hospital without any lasting sequelae. Conclusions: Patients with aortic stenosis most often develop symmetric hypertrophy; however, a small subset has asymmetric septal hypertrophy leading to left ventricular outflow tract obstruction. In cases of severe aortic stenosis, however, evidence of left ventricular outflow tract obstruction via both symptoms and echocardiographic findings may be minimized due to extremely high afterload on the left ventricle. Diagnosing a left ventricular outflow tract obstruction as the cause of hemodynamic instability during transcatheter aortic valve replacement, in the absence of abnormal findings on echocardiogram preoperatively, requires a high index of clinical suspicion. The management of acute onset left ventricular outflow tract obstruction intraoperatively consists primarily of medical therapy, including rate control, adequate volume resuscitation, and avoidance of inotropes. With persistently elevated gradients, interventional treatments may be considered. © 2018 The Author(s).
引用
收藏
相关论文
共 50 条
  • [1] TRANSCATHETER AORTIC VALVE REPLACEMENT IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY: A NATIONAL DATABASE ANALYSIS
    Park, Kyeeun
    Wu, Fangcheng
    Aung, Pyi Phyo
    Xi, Qianlan
    Cu, Cameron J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 1100 - 1100
  • [2] Association of Hypertrophic Obstructive Cardiomyopathy With Outcomes Following Transcatheter Aortic Valve Replacement
    Bandyopadhyay, Dhrubajyoti
    Chakraborty, Sandipan
    Amgai, Birendra
    Kapadia, Samir R.
    Braunwald, Eugene
    Naidu, Srihari S.
    Kalra, Ankur
    JAMA NETWORK OPEN, 2020, 3 (02)
  • [3] Hypertrophic Cardiomyopathy Is Associated With Increased Mortality During Transcatheter Aortic Valve Replacement
    DiMeglio, Matthew
    Ullah, Waqas
    Brailovsky, Yevgeniy
    Rajapreyar, Indranee
    Vishnevsky, Alec
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (12) : B180 - B180
  • [4] Transcatheter Aortic Valve Replacement for Aortic Regurgitation After Septal Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy
    Russo, Domitilla
    Musumeci, Maria Beatrice
    Nerla, Roberto
    Limite, Luca Rosario
    Arcari, Luca
    Casenghi, Matteo
    Castriota, Fausto
    Autore, Camillo
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2021, 28 : S225 - S226
  • [5] Case report: takotsubo cardiomyopathy after transcatheter aortic valve-in-valve replacement
    Steinecker, Matthieu
    Benvenuti, Christophe
    Digne, Franck
    Nejjari, Mohammed
    EUROPEAN HEART JOURNAL-CASE REPORTS, 2021, 5 (01)
  • [6] A case of hypertrophic cardiomyopathy with previous aortic valve replacement
    Xiao, Hongyan
    Song, Laichun
    Guo, Meng
    Tao, Liang
    JOURNAL OF CARDIOTHORACIC SURGERY, 2024, 19 (01)
  • [7] A case of hypertrophic cardiomyopathy with previous aortic valve replacement
    Hongyan Xiao
    Laichun Song
    Meng Guo
    Liang Tao
    Journal of Cardiothoracic Surgery, 19
  • [8] Transcatheter Versus Surgical Aortic Valve Replacement in Hypertrophic Cardiomyopathy Patients with Aortic Stenosis
    Mhanna, Mohammed
    Minhas, Abdul Mannan Khan
    Ariss, Robert W.
    Ahuja, Keerat Rai
    Mostafa, Abdelmonem
    Nazir, Salik
    Sheikh, Mujeeb
    CURRENT PROBLEMS IN CARDIOLOGY, 2023, 48 (08)
  • [9] Transcatheter Aortic Valve Replacement in Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis
    Ahmed, Ashraf
    Kaddoura, Rasha
    Aggarwal, Abhinav
    Zinyandu, Tawanda
    Webber, Fabricio
    Davila, Carlos
    Zarich, Stuart
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2025, 105 (04) : 754 - 760
  • [10] Transcatheter Aortic Valve Replacement forAortic Valve Stenosis Case Report
    Bump, Jamie
    Tennyson, Carolina
    DIMENSIONS OF CRITICAL CARE NURSING, 2025, 44 (01)